,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,regulation of mRNA stability (GO:0043488),0.7312656351690533,2.037845390923597,0.0,0.002983223213782286,0.003,11/16,16.62%,SET;HNRNPU;NPM1;FUS;YBX1;THRAP3;DHX36;HNRNPD;FMR1;PSME4;TAF15
1,regulation of translation (GO:0006417),0.6764642301411901,1.9386620199658815,0.0,0.012927300593056575,0.024,11/20,15.32%,NCL;NPM1;DHX9;CNOT1;YBX1;DHX36;HNRNPD;SOX4;FMR1;EIF1;DDX1
2,"positive regulation of gene expression, epigenetic (GO:0045815)",0.6214288829520824,1.8380792014601917,0.0,0.03513574007343581,0.085,8/24,5.01%,ACTB;SMARCA5;DEK;SF3B1;DDX21;ATAD2;MYBBP1A;BAZ1B
4,nucleosome organization (GO:0034728),0.5556776556498622,1.764860522679073,0.0,0.05767564879979087,0.205,14/37,10.31%,SET;SMARCA5;NPM1;ATRX;NAP1L1;SMARCC1;BRD2;SMARCA4;HMGB2;BPTF;NASP;ANP32B;ANP32E;CTCF
14,positive regulation of gene expression (GO:0010628),0.4895782912154678,1.6363617506137895,0.0,0.09194956883368957,0.646,35/64,33.43%,ACTB;SMARCA5;DDX5;NPM1;HMGA2;DEK;SF3B1;DDX21;MYBBP1A;BAZ1B;DHX36;HNRNPD;SOX4;GSK3B;FMR1;CTCF;MED1;POLR2A;CITED2;DNMT1;NFE2L2;SP1;SOX11;SETX;ATF4;HIF1A;EP300;SRPK2;ETS1;ID2;RBPJ;POLR1A;APP;SMAD1;HCFC1
5,regulation of cell differentiation (GO:0045595),0.5830976387460094,1.7527318348667813,0.0010121457489878543,0.05833858729174248,0.245,15/24,29.73%,DDX5;PURB;PA2G4;CDK6;ANP32B;DDX17;SUZ12;ZFHX3;REST;RUNX2;ATF4;CREBBP;RUNX1;SIX1;ID2
25,regulation of apoptotic process (GO:0042981),0.4596151242936756,1.5251305426601065,0.002,0.16132353225299595,0.939,28/68,25.23%,PTMA;TOP2A;NPM1;ANKRD1;HMGA2;PA2G4;BCLAF1;CCAR1;MTDH;ACTN1;ANP32B;SOX4;GSK3B;ACTN4;ANP32E;MED1;CITED2;CTNNB1;HMGB1;JUN;REST;SETX;RRP1B;ZBTB7A;NFKB1;ATF4;C1QBP;CREBBP
8,ATP-dependent chromatin remodeling (GO:0043044),0.5573287924629998,1.6961163514634865,0.0020242914979757085,0.07877919079358407,0.428,13/29,19.02%,ACTB;SMARCA5;CHD4;PBRM1;SMARCC1;CHD3;SMARCA4;NASP;ANP32E;CHD8;GATAD2B;SMARCAD1;RBBP4
3,chromatin assembly (GO:0031497),0.5979360558796211,1.7780707180846549,0.0020554984583761563,0.06314489135839173,0.183,9/23,10.31%,SMARCA5;NPM1;HMGA2;ATRX;NAP1L1;BRD2;HMGB2;ANP32B;CTCF
6,RNA processing (GO:0006396),0.6244615495185959,1.7343576974938504,0.002074688796680498,0.06406826997218149,0.299,13/17,27.63%,HNRNPU;SF3B1;FUS;RBM39;TCERG1;SFPQ;HNRNPD;DDX17;DICER1;NONO;SETX;NUDT21;SRPK2
45,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3846836473392712,1.3590727408490486,0.003,0.3511143232873092,1.0,93/187,38.34%,HNRNPU;TPR;CCND1;DDX5;HMGA2;CBX5;ENO1;ATRX;NFIX;HDGF;CNOT1;MTDH;TCERG1;CHD3;NFIC;SMARCA4;SFPQ;RIF1;NIPBL;BPTF;NCOR1;CBX6;CTCF;NSD1;LRRFIP1;CUX1;CHD8;MED1;EZH2;GATAD2B;KDM1A;MIER1;AEBP1;SPEN;NFIB;CITED2;KMT5A;ID3;N4BP2L2;TAF1;DICER1;FOXP1;HMGB1;JUN;YY1;TCF25;KLF7;SKIL;ZFHX3;TBL1X;SOX11;REST;NR3C1;PURA;ZBTB7A;NFKB1;NR2C2;ATF4;IRF2BPL;EP300;C1QBP;TAF3;CREBBP;RUNX1;PEG3;MEF2A;DCAF1;NR4A2;MTF2;HES1;MEIS2;PRDM2;ID2;NCOR2;ZEB2;E2F8;RBPJ;SIN3A;HCFC1;NFX1;TRIM37;UHRF1;SNW1;CTR9;GLI3;E2F7;PARP1;PHF12;HDAC2;TRIM33;NRIP1;CGGBP1;SOX9
12,"regulation of gene expression, epigenetic (GO:0040029)",0.5188814310271125,1.6499634812741797,0.004008016032064128,0.09240342672433338,0.606,14/39,16.02%,ACTB;SMARCA5;DEK;SF3B1;DDX21;MYBBP1A;BAZ1B;MPHOSPH8;CTCF;EZH2;RBBP7;AEBP2;DNMT1;SUZ12
10,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.5469847842562064,1.6682790597179074,0.004056795131845842,0.08976789852381244,0.535,14/29,19.62%,HNRNPU;DDX5;SF3B1;DHX9;FUS;CCAR1;YBX1;SFPQ;HNRNPD;POLR2A;SPEN;CDC5L;YTHDC1;NONO
7,mitotic sister chromatid segregation (GO:0000070),0.608445261513925,1.7062077034883645,0.0041797283176593526,0.07806100742730315,0.395,8/16,19.52%,SET;SMC4;SMC2;SMC1A;NIPBL;RAD21;KMT5A;NAA50
18,"mRNA splicing, via spliceosome (GO:0000398)",0.5184723001443614,1.6136792927733492,0.006024096385542169,0.09075279039821901,0.716,16/35,19.62%,HNRNPU;DDX5;SF3B1;DHX9;FUS;CCAR1;YBX1;SFPQ;HNRNPD;DDX17;POLR2A;SPEN;DDX1;CDC5L;YTHDC1;NONO
16,positive regulation of programmed cell death (GO:0043068),0.5453174525143688,1.624434158089923,0.006091370558375634,0.09224594133597384,0.684,13/25,25.03%,TOP2A;ANKRD1;HMGA2;BCLAF1;CCAR1;SOX4;CTNNB1;HMGB1;JUN;REST;RRP1B;ATF4;C1QBP
17,positive regulation of apoptotic process (GO:0043065),0.5403464948673616,1.622996777885823,0.007099391480730223,0.08806032968090674,0.687,15/27,27.63%,TOP2A;ANKRD1;HMGA2;BCLAF1;MYBBP1A;CCAR1;SOX4;CTNNB1;HMGB1;JUN;REST;RRP1B;ATF4;C1QBP;SRPK2
9,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5774744797853408,1.6727778063450722,0.0071794871794871795,0.09347432736517831,0.514,13/21,27.63%,NCL;HNRNPU;DDX5;RBM39;THRAP3;FMR1;DDX17;YTHDC1;REST;ZBTB7A;RBFOX2;C1QBP;SRPK2
65,regulation of transcription by RNA polymerase II (GO:0006357),0.3447739553021496,1.2475653220968819,0.009,0.489462787188464,1.0,209/487,38.04%,HNRNPU;TPR;CCND1;SMARCA5;DDX5;NPM1;NUCKS1;ANKRD1;HMGA2;CBX5;ENO1;DEK;ATRX;PURB;CHD4;DHX9;FUS;ATAD2;NFIX;BCLAF1;SMARCC1;HDGF;CNOT1;BAZ1B;BRD2;YBX1;MTDH;TCERG1;CHD3;NFIC;SMARCA4;SFPQ;RIF1;NIPBL;KMT2A;THRAP3;HMGB2;BPTF;NCOR1;CBX6;DHX36;PSIP1;BRD3;SOX4;ZBTB20;RAD21;NFAT5;BAZ1A;CTCF;CHD1;CEBPZ;NSD1;BRD7;DDX17;LRRFIP1;BBX;CUX1;PBX1;CHD8;ZBTB38;MED1;EZH2;KLF5;CLOCK;MED13;ASXL2;GATAD2B;KDM1A;ZFHX4;MIER1;BRD4;KLF6;AEBP2;AEBP1;ARID4B;SPEN;USP16;KAT6A;BRD8;NFIB;CITED2;PHF20;KMT5A;MAFG;ID3;N4BP2L2;CTNNB1;TAF1;DICER1;CDC5L;FOXP1;JMJD1C;MGA;HMGB1;JUN;YY1;NFE2L2;SP1;TCF25;KLF7;SKIL;ZFHX3;TBL1X;SOX11;REST;NR3C1;CDK4;PURA;SETX;RRP1B;TMF1;TCF20;ZBTB7A;RUNX2;NFKB1;NR2C2;ATF4;IRF2BPL;HIF1A;CCNT1;EP300;VEZF1;TCF12;RBBP8;INO80;C1QBP;TAF3;CREBBP;RUNX1;MYSM1;SSBP3;PEG3;NPAT;ARID1A;POU2F1;MED13L;WWTR1;TEAD1;MEF2A;TET3;DCAF1;SIX1;NR4A2;KLF3;MTF2;HES1;KLF13;MEIS2;ENY2;SP3;TCF4;PRRX1;PRDM2;ETS1;SAFB;ID2;ZMIZ1;RSF1;ARID4A;RCOR1;NCOR2;ZEB2;E2F8;OGT;KMT2C;RFX7;SMARCD1;RBPJ;APP;SMAD1;ZFX;KDM2A;MLLT10;SIN3A;HCFC1;E2F3;NFX1;CHD2;SMARCC2;TRIM37;GLYR1;CCNT2;CREB1;NFE2L1;ATF6;NCOA6;UHRF1;KANSL3;NCOA7;DOT1L;SNW1;HIPK2;ATAD2B;CTR9;GLI3;E2F7;TSHZ1;PARP1;GTF2F1;PHF12;EPC2;RNF4;PCBP1;HDAC2;TRIM33;NRIP1;NACC1;BRIP1;CGGBP1
19,mRNA processing (GO:0006397),0.5119735462280401,1.597927660109393,0.00906344410876133,0.10197651352445783,0.767,15/35,19.62%,HNRNPU;DDX5;SF3B1;DHX9;FUS;CCAR1;YBX1;TCERG1;SFPQ;HNRNPD;POLR2A;SPEN;CDC5L;YTHDC1;NONO
20,positive regulation of response to DNA damage stimulus (GO:2001022),0.5338858813534058,1.5898025011223487,0.009202453987730062,0.10583339496513348,0.785,7/24,9.61%,DDX5;ANKRD1;HMGA2;DHX9;BCLAF1;SMCHD1;FMR1
13,nucleosome assembly (GO:0006334),0.557703593274729,1.637474866785497,0.0102880658436214,0.09766504568930104,0.641,8/22,8.01%,SMARCA5;NPM1;ATRX;NAP1L1;BRD2;HMGB2;NASP;ANP32B
11,cellular response to light stimulus (GO:0071482),0.6027983192513766,1.6650589479023106,0.011554621848739496,0.08576766739624073,0.553,11/16,25.23%,NPM1;DHX36;FMR1;KDM1A;TAF1;YY1;PCNA;ATF4;EP300;INO80;CREBBP
40,chromatin organization (GO:0006325),0.4186299772304229,1.4035462418275801,0.013,0.28745841684137147,1.0,36/74,34.03%,SMARCA5;NPM1;NUCKS1;HMGA2;ATRX;PBRM1;TOP1;SMARCC1;BAZ1B;SMARCA4;HMGB2;BPTF;BAZ1A;CHD1;EZH2;SETD5;HMGN1;CBX3;SETD2;SMARCAD1;RBBP4;KDM5A;ZBTB7A;PAK1;INO80;HP1BP3;MYSM1;ARID1A;MTF2;BAZ2A;SAFB;RSF1;SMARCD1;EHMT1;HCFC1;SMARCC2
15,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.5972276747216279,1.629281118426775,0.013727560718057022,0.09291497301259413,0.666,7/15,15.32%,DDX21;MTDH;ANKRD17;DHX36;MIER1;BRD4;DDX1
31,chromatin remodeling (GO:0006338),0.43755259321421797,1.4488483866326347,0.014,0.2512122547939167,0.996,25/64,26.03%,ACTB;SMARCA5;NPM1;HMGA2;ATRX;CHD4;PBRM1;TOP1;SMARCC1;BAZ1B;CHD3;SMARCA4;BPTF;BAZ1A;CHD8;GATAD2B;CBX3;SMARCAD1;RBBP4;KDM5A;ZBTB7A;PAK1;INO80;MYSM1;ARID1A
22,DNA replication-independent nucleosome assembly (GO:0006336),0.5671847498050322,1.579058089515553,0.016684045881126174,0.10765544641040424,0.814,11/17,29.93%,SMARCA5;NPM1;ATRX;NASP;HJURP;RBBP7;RBBP4;UBN1;CENPA;CABIN1;RSF1
34,negative regulation of gene expression (GO:0010629),0.43232293274757927,1.429383214997799,0.018018018018018018,0.27720578059047557,0.998,27/58,30.23%,NCL;CNOT1;YBX1;NCOR1;MPHOSPH8;DHX36;FMR1;EZH2;HELLS;RBBP7;AEBP2;CITED2;DNMT1;SUZ12;TAF1;DICER1;FOXP1;YY1;RBBP4;SOX11;REST;NFKB1;HIF1A;RUNX1;MTF2;ID2;NCOR2
37,negative regulation of cellular process (GO:0048523),0.4281790293577593,1.4136726511720676,0.019,0.2876257192243066,1.0,20/59,21.72%,LMNA;NPM1;ENO1;PBRM1;CDK6;ACTN1;SMARCA4;ANP32B;SOX4;CTCF;BRD7;RBBP7;UBR2;SUZ12;CTNNB1;RBBP4;SOX11;REST;JADE1;ARID2
21,cellular response to UV (GO:0034644),0.5587157816421066,1.5812122878866064,0.020855057351407715,0.11065046102028844,0.808,11/18,25.23%,NPM1;DHX36;FMR1;KDM1A;TAF1;YY1;PCNA;ATF4;EP300;INO80;CREBBP
30,double-strand break repair (GO:0006302),0.4542109396947521,1.454994247406033,0.02112676056338028,0.24658104133703695,0.996,28/43,40.74%,SMARCA5;NUCKS1;BAZ1B;SFPQ;RIF1;NSD2;HMGB2;POLA1;RAD21;DDX1;BRCA2;SMARCAD1;HMGB1;YY1;SETX;SFR1;RBBP8;INO80;HPF1;RNF168;KDM2A;MORF4L1;PARP1;BRIP1;WRN;RPA1;PARP2;BRCA1
41,positive regulation of cellular process (GO:0048522),0.4149417057612312,1.3951555513023912,0.023,0.2982253059891626,1.0,28/67,29.53%,LMNA;CCND1;NPM1;HMGA2;PA2G4;NAP1L1;BCLAF1;CCAR1;ANKRD17;DHX36;SOX4;FMR1;ACTN4;CNOT6;EZH2;CITED2;DICER1;ZFHX3;SOX11;CDK4;PAK1;INO80;C1QBP;WWTR1;SRPK2;HES1;MEIS2;ETS1
23,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5420316101393877,1.5416814372735566,0.026232948583420776,0.14945119627934314,0.917,10/17,29.83%,DDX5;UBE3A;DDX17;MED1;NR3C1;TMF1;RBFOX2;ARID1A;SAFB;ZMIZ1
27,response to UV (GO:0009411),0.49643576727467864,1.4825660424181413,0.026476578411405296,0.21734911986128086,0.986,13/25,25.23%,CCND1;NPM1;DHX36;FMR1;KDM1A;TAF1;PCLAF;YY1;PCNA;ATF4;EP300;INO80;CREBBP
26,regulation of cell migration (GO:0030334),0.5101709693967946,1.4831686379662872,0.03363914373088685,0.2242205299445254,0.986,9/21,22.92%,LMNA;CCAR1;ACTN4;SYNE2;ZMYND8;CITED2;ARID2;RNF20;PAK1
72,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33712711001501555,1.208951305273296,0.038,0.5457503022805882,1.0,140/267,44.14%,HNRNPU;SMARCA5;NPM1;HMGA2;ATRX;DHX9;ATAD2;NFIX;BCLAF1;YBX1;TCERG1;NFIC;SMARCA4;SFPQ;KMT2A;THRAP3;HMGB2;BPTF;DHX36;SOX4;NFAT5;CEBPZ;DDX17;PBX1;CHD8;ZBTB38;MED1;KLF5;CLOCK;MED13;ASXL2;KDM1A;BRD4;KLF6;USP16;KAT6A;BRD8;NFIB;CITED2;CTNNB1;CDC5L;HMGB1;JUN;YY1;NFE2L2;SP1;KLF7;ZFHX3;TBL1X;SOX11;REST;NR3C1;SETX;RRP1B;TMF1;TCF20;RUNX2;NFKB1;NR2C2;ATF4;IRF2BPL;HIF1A;CCNT1;EP300;VEZF1;TCF12;INO80;CREBBP;RUNX1;MYSM1;SSBP3;PEG3;NPAT;POU2F1;WWTR1;TEAD1;MEF2A;TET3;SIX1;NR4A2;MTF2;HES1;MEIS2;SP3;TCF4;PRDM2;ETS1;ZMIZ1;RSF1;ZEB2;E2F8;OGT;KMT2C;SMARCD1;RBPJ;APP;SMAD1;MLLT10;SIN3A;HCFC1;E2F3;GLYR1;CCNT2;CREB1;ATF6;NCOA6;UHRF1;KANSL3;NCOA7;DOT1L;SNW1;HIPK2;ATAD2B;GLI3;E2F7;PARP1;GTF2F1;RNF4;PCBP1;HDAC2;NRIP1;SOX9;ATF2;SQSTM1;MED14;BCLAF3;TBL1XR1;BRCA1;JUNB;SKI;ELK3;CTBP2;FOXJ3;FOSL1;CEBPG;ATF1;RBL1;NME2;RLF;GABPA
24,RNA metabolic process (GO:0016070),0.5441250346768813,1.5267997912384847,0.03802672147995889,0.16439548723416253,0.937,10/17,24.12%,HNRNPU;DHX9;RBM39;DHX36;HNRNPD;DDX17;POLR2A;DICER1;SETX;RBFOX2
73,"negative regulation of transcription, DNA-templated (GO:0045892)",0.33655983395500244,1.204653964649948,0.043,0.550629446335651,1.0,120/268,38.34%,SET;HNRNPU;TPR;CCND1;DDX5;HMGA2;CBX5;ENO1;PA2G4;NFIX;BCLAF1;MYBBP1A;HDGF;CNOT1;MTDH;TCERG1;CHD3;NFIC;SMARCA4;SFPQ;RIF1;NIPBL;HMGB2;BPTF;NCOR1;CBX6;MPHOSPH8;BASP1;CTCF;NSD1;BRD7;LRRFIP1;CUX1;CHD8;ZBTB38;MED1;EZH2;CLOCK;GATAD2B;KDM1A;MIER1;CBX3;AEBP1;SPEN;KAT6A;CITED2;KMT5A;ID3;N4BP2L2;CTNNB1;TAF1;DICER1;FOXP1;HMGB1;JUN;YY1;TCF25;KLF7;SKIL;NONO;ZFHX3;TBL1X;SOX11;REST;NR3C1;ZMYND11;PURA;ZBTB7A;RUNX2;NFKB1;NR2C2;ATF4;IRF2BPL;EP300;RBFOX2;BTAF1;C1QBP;TAF3;CREBBP;RUNX1;PEG3;POU2F1;MEF2A;DCAF1;NR4A2;MTF2;HES1;MEIS2;SP3;PRDM2;ID2;RSF1;ARID4A;RCOR1;NCOR2;ZEB2;E2F8;RLIM;RBPJ;EHMT1;KDM2A;SIN3A;HCFC1;NFX1;SMARCC2;TRIM37;CREB1;UHRF1;SNW1;CTR9;GLI3;E2F7;PARP1;PHF12;HDAC2;TRIM33;NRIP1;NACC1;CGGBP1;SOX9
32,regulation of stem cell differentiation (GO:2000736),0.5353014552267396,1.448351385589638,0.04867724867724868,0.2447749713692274,0.996,8/15,28.23%,HNRNPU;KMT2A;PSME4;TCF12;RUNX1;PSMC6;NUDT21;HES1
38,gene expression (GO:0010467),0.4742092081306979,1.4058007227000542,0.05263157894736842,0.2973802508896658,1.0,13/26,29.23%,PTMA;HNRNPU;TPR;RBM39;HNRNPD;NUP153;DDX17;POLR2A;YTHDC1;SETX;MEF2A;NR4A2;BAZ2A
33,organelle organization (GO:0006996),-0.3384146341463415,-1.4427002692441089,0.05660377358490566,0.3434508046445305,0.22684703433922998,15/15,66.77%,PHB;AJUBA;TFB2M;MYC;TFAM;PARK7;PPRC1;NRF1;ATXN7;SSBP1;GABPA;LIMD1;VMP1;PARP1;HCFC1
29,regulation of cellular response to stress (GO:0080135),0.5215264609257391,1.4615666254831914,0.05705394190871369,0.24177366801475547,0.995,8/17,25.23%,TPR;NPM1;GSK3B;NUP153;DNAJC2;ATF4;EP300;CREBBP
36,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.4969910528071236,1.4153100560631298,0.057971014492753624,0.2918586710817003,1.0,8/19,20.62%,DDX21;MTDH;ANKRD17;DHX36;MIER1;BRD4;DDX1;ZMYND11
28,positive regulation of developmental process (GO:0051094),0.5404294839203306,1.4756363192113233,0.05925925925925926,0.22250730384176154,0.989,8/15,25.03%,LMNA;PA2G4;RIF1;BASP1;FMR1;REST;NR2C2;C1QBP
35,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5283776975619552,1.4282338491591695,0.06680805938494168,0.271871075549359,0.998,7/15,22.52%,NPM1;DHX9;HNRNPD;SOX4;FMR1;PCNA;NFKB1
44,protein-DNA complex assembly (GO:0065004),0.44901816275163603,1.3635477337291706,0.07614213197969544,0.3484043110883918,1.0,7/29,8.01%,SMARCA5;NPM1;ATRX;NAP1L1;BRD2;HMGB2;ANP32B
39,generation of neurons (GO:0048699),0.488437703933454,1.4047674707874984,0.08144329896907217,0.2922283867791349,1.0,11/19,28.23%,CDK6;HMGB2;CTNNB1;SOX11;RUNX2;NAV1;RUNX1;MYEF2;SIX1;NR4A2;HES1
48,positive regulation of intracellular signal transduction (GO:1902533),0.4317388350768307,1.3437778691499247,0.08450704225352113,0.36542412686045656,1.0,14/33,25.03%,DDX21;BCLAF1;MTDH;ANKRD17;DHX36;NFAT5;ACTN4;MIER1;BRD4;DDX1;HMGB1;SOX11;EP300;C1QBP
43,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.48522267485136755,1.3682160543518944,0.0875,0.34522136539024784,1.0,10/18,29.53%,DDX5;SMARCA4;KLF5;NFIB;JUN;REST;NR3C1;HIF1A;TEAD1;ETS1
54,cellular response to cytokine stimulus (GO:0071345),0.4210464859243533,1.2972381046980703,0.10030090270812438,0.4358820584581896,1.0,7/33,9.71%,HNRNPU;TPR;CCND1;ANKRD1;DHX9;GSK3B;NFAT5
46,positive regulation of cellular biosynthetic process (GO:0031328),0.4756438886874435,1.3458508255585406,0.100418410041841,0.3757564195794471,1.0,8/19,23.32%,NPM1;DHX9;HNRNPD;SOX4;FMR1;SP1;PCNA;HIF1A
60,positive regulation of macromolecule metabolic process (GO:0010604),0.39044368199733537,1.2714428290617406,0.1031031031031031,0.45978099109304543,1.0,26/48,38.74%,HMGA2;ANXA2;MPHOSPH8;DHX36;GSK3B;FMR1;CTCF;MED1;RESF1;CITED2;DNMT1;NFE2L2;SP1;SOX11;ATF4;HIF1A;SRPK2;ETS1;ID2;RBPJ;APP;SMAD1;HCFC1;PPHLN1;SOX9;ATF2
42,protein localization to nucleus (GO:0034504),0.4999881850985589,1.3788987909583763,0.10684647302904564,0.3276099968976627,1.0,3/16,1.00%,LMNA;HNRNPU;TPR
90,"regulation of transcription, DNA-templated (GO:0006355)",0.3119333732814618,1.1278170195194661,0.114,0.6526960922509667,1.0,201/492,37.94%,SET;SMARCA5;DDX5;NPM1;NUCKS1;ANKRD1;HMGA2;CBX5;ENO1;DEK;ATRX;PURB;CHD4;PA2G4;DHX9;FUS;ATAD2;NFIX;BCLAF1;MYBBP1A;SMARCC1;HDGF;CCAR1;BAZ1B;BRD2;YBX1;MTDH;CHD3;NFIC;SMARCA4;SFPQ;NIPBL;NSD2;KMT2A;THRAP3;HMGB2;BPTF;NCOR1;SBNO1;MPHOSPH8;POLA1;DHX36;PSIP1;HNRNPD;BRD3;BASP1;SOX4;ZBTB20;RAD21;KMT2E;NFAT5;BAZ1A;CTCF;CHD1;NSD1;BRD7;DDX17;LRRFIP1;BBX;CUX1;PBX1;CHD8;ZBTB38;MED1;EZH2;KLF5;SETD5;CLOCK;MED13;KDM1A;ZFHX4;BRD4;CBX3;POLR2A;KLF6;AEBP2;ARID4B;SPEN;USP16;KAT6A;NFIB;CITED2;PHF20;KMT5A;MAFG;ID3;TAF15;DNAJC2;CTNNB1;BRCA2;CDC5L;FOXP1;JMJD1C;MGA;HMGB1;JUN;YY1;NFE2L2;SP1;KLF7;NONO;ZFHX3;TBL1X;SOX11;KDM5A;CHD7;REST;NR3C1;ZMYND11;PURA;SFR1;PCNA;TCF20;RNF20;ZBTB7A;RUNX2;NFKB1;NR2C2;ATF4;NSD3;IRF2BPL;HIF1A;CCNT1;EP300;VEZF1;TCF12;RBFOX2;RBBP8;BTAF1;HP1BP3;CREBBP;RUNX1;PEG3;NPAT;ARID1A;POU2F1;MED13L;WWTR1;TEAD1;MEF2A;SIX1;NR4A2;KLF3;MTF2;HES1;KLF13;MEIS2;ENY2;SP3;TCF4;BAZ2A;PRRX1;PRDM2;ETS1;SAFB;ID2;ZMIZ1;RSF1;ARID4A;RCOR1;NCOR2;ZEB2;E2F8;OGT;RLIM;RFX7;SMARCD1;RBPJ;WAC;SMAD1;EHMT1;ZFX;KDM2A;SIN3A;HCFC1;E2F3;NFX1;CHD2;SMARCC2;UBE2L3;CCNT2;CREB1;NFE2L1;ATF6;NCOA6;NCOA7;SNW1;HIPK2;CTR9;GLI3;E2F7;TSHZ1;PHF12;EPC2;RNF4;FOXN2;GPBP1;HDAC2;TRIM33;NACC1;BRIP1
49,"negative regulation of gene expression, epigenetic (GO:0045814)",0.47740409350884644,1.339042452018456,0.1148577449947313,0.3698993844735356,1.0,7/16,19.02%,MPHOSPH8;EZH2;RBBP7;AEBP2;DNMT1;SUZ12;RBBP4
50,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.47113515709131276,1.3171419624777774,0.11795407098121086,0.4173728157629004,1.0,9/17,29.73%,CCND1;CDK6;ANKRD17;KMT2E;BRD7;CDK4;JADE1;INO80;ID2
89,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3144958011950879,1.1356849377255607,0.118,0.6367673190137314,1.0,143/333,37.74%,HNRNPU;SMARCA5;NPM1;HMGA2;ATRX;DHX9;ATAD2;NFIX;BCLAF1;SMARCC1;YBX1;WDR43;TCERG1;NFIC;SMARCA4;SFPQ;KMT2A;THRAP3;HMGB2;BPTF;DHX36;HNRNPD;SOX4;KMT2E;NFAT5;CTCF;CEBPZ;NSD1;BRD7;DDX17;PBX1;CHD8;ZBTB38;MED1;KLF5;CLOCK;MED13;HMGN1;ASXL2;KDM1A;BRD4;KLF6;USP16;KAT6A;BRD8;NFIB;CITED2;TAF15;DNAJC2;CTNNB1;BRCA2;CDC5L;HMGB1;JUN;YY1;NFE2L2;SP1;KLF7;ZFHX3;TBL1X;SOX11;KDM5A;UBTF;REST;NR3C1;SETX;RRP1B;SFR1;TMF1;TCF20;RNF20;RUNX2;NFKB1;NR2C2;ATF4;NSD3;IRF2BPL;HIF1A;CCNT1;EP300;VEZF1;TCF12;INO80;CREBBP;RUNX1;MYSM1;SSBP3;PEG3;NPAT;ARID1A;POU2F1;WWTR1;TEAD1;MEF2A;TET3;SIX1;NR4A2;MTF2;HES1;MEIS2;ENY2;SP3;TCF4;PRDM2;ETS1;ID2;ZMIZ1;RSF1;ZEB2;E2F8;OGT;KMT2C;SMARCD1;RBPJ;WAC;APP;SERTAD2;SMAD1;MLLT10;SIN3A;HCFC1;E2F3;SMARCC2;GLYR1;CCNT2;CREB1;ATF6;NCOA6;UHRF1;KANSL3;NCOA7;DOT1L;SNW1;HIPK2;ATAD2B;GLI3;E2F7;PARP1;GTF2F1;RNF4;PCBP1;HDAC2;NRIP1
47,recombinational repair (GO:0000725),0.47956602798396536,1.3442229876713336,0.11962224554039874,0.3718661787619678,1.0,12/16,40.74%,NUCKS1;SFPQ;BRCA2;YY1;SFR1;RBBP8;INO80;MORF4L1;PARP1;WRN;RPA1;BRCA1
52,regulation of DNA binding (GO:0051101),0.47511723385706217,1.304620176093404,0.1248688352570829,0.432643858901349,1.0,12/16,42.84%,HMGA2;HMGB2;HJURP;KDM1A;HMGB1;JUN;ZBTB7A;HES1;RSF1;DOT1L;SKI;CEBPG
59,chromosome organization (GO:0051276),0.4165276983495456,1.2854997634226732,0.1292929292929293,0.42926390978429974,1.0,8/31,12.61%,TOP2A;NUCKS1;HMGA2;SMARCA4;HMGB2;TOP2B;EZH2;HMGN1
62,negative regulation of programmed cell death (GO:0043069),0.40446537877020705,1.2627790052861911,0.1404040404040404,0.4688311707638173,1.0,11/36,22.52%,PTMA;NPM1;HMGA2;PA2G4;MTDH;GSK3B;MED1;CITED2;CTNNB1;SETX;NFKB1
80,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33591286794142866,1.1664754428046356,0.141,0.6111381355367496,1.0,43/121,29.43%,NUCKS1;HMGA2;ATRX;SMC3;FUS;MYBBP1A;CCAR1;YBX1;CHD3;SFPQ;NSD2;SBNO1;ANKRD17;HNRNPD;SOX4;NSD1;ZBTB38;EZH2;CLOCK;POLR2A;BRCA2;JMJD1C;SP1;NONO;ZFHX3;SOX11;CHD7;REST;NR3C1;RNF20;NR2C2;ATF4;NSD3;HIF1A;EP300;HP1BP3;CREBBP;WWTR1;SIX1;MTF2;SP3;BAZ2A;PRDM2
81,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3331850680719359,1.1654978478545104,0.143,0.6064414004708534,1.0,57/151,29.93%,NPM1;HMGA2;ATAD2;SMARCC1;SMARCA4;KMT2A;THRAP3;HMGB2;HNRNPD;SOX4;KMT2E;CTCF;NSD1;BRD7;CHD8;MED1;CLOCK;MED13;BRD4;KLF6;USP16;KAT6A;NFIB;CITED2;TAF15;DNAJC2;CTNNB1;BRCA2;JUN;SP1;ZFHX3;TBL1X;SOX11;KDM5A;REST;SFR1;RNF20;RUNX2;NFKB1;ATF4;NSD3;HIF1A;EP300;CREBBP;RUNX1;NPAT;ARID1A;TEAD1;SIX1;HES1;ENY2;SP3;TCF4;ETS1;ID2;ZMIZ1;RSF1
56,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4756662193619943,1.293593816439657,0.14421052631578948,0.430294434026026,1.0,9/15,34.23%,NPM1;DHX9;MTDH;CLOCK;ZBTB7A;NFKB1;EP300;APP;TRIM37
51,regulation of androgen receptor signaling pathway (GO:0060765),0.470957948853334,1.305190155733383,0.1444906444906445,0.439567216545803,1.0,7/16,23.82%,DDX5;SMARCA4;NCOR1;KDM1A;FOXP1;ZBTB7A;EP300
55,double-strand break repair via homologous recombination (GO:0000724),0.44722733870223175,1.295668521829298,0.1446280991735537,0.43263968656118984,1.0,14/20,40.74%,NUCKS1;SFPQ;NIPBL;RAD21;BRCA2;YY1;SFR1;RBBP8;INO80;MORF4L1;PARP1;WRN;RPA1;BRCA1
53,positive regulation of angiogenesis (GO:0045766),0.4681654355750539,1.30355020087546,0.14629049111807732,0.4270887422347559,1.0,13/16,47.45%,HMGA2;PKM;MTDH;SP1;HIF1A;RUNX1;ETS1;ITGA5;SMAD1;HIPK2;BRCA1;HIPK1;ECM1
61,positive regulation of cell cycle (GO:0045787),0.4637232647175502,1.2654183161013939,0.1638655462184874,0.46914852934120443,1.0,8/15,33.43%,CCND1;ANKRD17;CITED2;CDK4;SRPK2;MEIS2;APP;HCFC1
57,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.46029961093824034,1.2921895859960713,0.1643835616438356,0.4264090163231967,1.0,8/16,26.33%,PSME4;NFE2L2;ATF4;HIF1A;EP300;INO80;CREBBP;PSMC6
58,brain development (GO:0007420),0.4551409406782177,1.2875940503714023,0.16996871741397288,0.43099002958654664,1.0,7/17,19.72%,NIPBL;BPTF;UBE3A;PBX1;CHD8;NFIB;ZFHX3
66,central nervous system development (GO:0007417),0.4065261287342684,1.2418735411738002,0.17276422764227642,0.497716139616586,1.0,10/27,20.22%,NIPBL;BPTF;UBE3A;SOX4;PBX1;CHD8;NFIB;ZFHX3;SOX11;CHD7
64,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4415140494248866,1.2525869253759387,0.18172484599589322,0.4825052795874745,1.0,7/19,24.12%,ACTB;GSK3B;POLR2A;WASF2;SETX;PAK1;RBFOX2
63,ribonucleoprotein complex assembly (GO:0022618),0.46397776961627846,1.2574770007856015,0.1825813221406086,0.4761950324687714,1.0,8/15,27.63%,SF3B1;DHX9;DDX1;DICER1;YTHDC1;SETX;NUDT21;SRPK2
82,cellular response to DNA damage stimulus (GO:0006974),0.3459800451024781,1.1604439638266117,0.19019019019019018,0.6142408089483194,1.0,38/74,41.54%,TOP2A;CCND1;NPM1;CBX5;SMC1A;BAZ1B;RIF1;NIPBL;POLA1;CBX1;FMR1;ZBTB38;CBX3;USP16;PSME4;TAF1;FOXP1;PCLAF;YY1;SETX;PAK1;RBBP8;INO80;HPF1;TLK2;WAC;RNF168;NCOA6;DOT1L;PARP1;ATF2;WRN;RPA1;PARP2;BRCA1;ASH2L;KMT5B;CDK1
76,negative regulation of apoptotic process (GO:0043066),0.3627231594093981,1.1833761672554028,0.201,0.5911884845101976,1.0,11/50,16.92%,PTMA;SET;NPM1;HMGA2;PA2G4;MTDH;SFPQ;GSK3B;MED1;CITED2;CTNNB1
67,cell cycle G1/S phase transition (GO:0044843),0.44865476760535183,1.2329625200257313,0.20168067226890757,0.5147024767699299,1.0,3/15,7.91%,CCND1;CDK6;NASP
70,protein polyubiquitination (GO:0000209),0.4197895220079538,1.218998978178036,0.2041025641025641,0.5311984077760049,1.0,12/19,40.74%,UBE3A;UBR2;PSME4;CTNNB1;TAF1;RNF20;PSMC6;RLIM;RNF168;UBE2L3;RNF4;BRCA1
85,transcription by RNA polymerase II (GO:0006366),0.33903851107993005,1.1458931275031323,0.206,0.6346427172598489,1.0,42/93,36.64%,DDX5;DEK;DDX21;NFIX;SSRP1;NFIC;NCOR1;MED1;POLR2A;SETD2;TAF15;TAF1;SP1;TBL1X;NR3C1;SETX;NFKB1;NR2C2;ATF4;CCNT1;TSC22D1;TAF3;CREBBP;POU2F1;WWTR1;NUDT21;TEAD1;NR4A2;KLF13;PRRX1;NCOR2;COPS2;RBPJ;TAF2;E2F3;NFX1;CCNT2;SNW1;CTR9;PARP1;GTF2I;GTF2F1
77,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3843385755556469,1.1824041187327465,0.21629778672032193,0.5865585071289077,1.0,10/29,22.52%,CCND1;BCLAF1;MED1;MED13;CTNNB1;JUN;CDK4;SETX;RUNX2;NFKB1
68,cellular component assembly (GO:0022607),0.4302274005669665,1.221492482282321,0.219435736677116,0.539787917976136,1.0,12/18,44.24%,ACTB;KMT2A;RAD21;RBBP4;CREBBP;TEAD1;HES1;LAMC1;SOX9;VMP1;CHAF1A;ADD1
71,positive regulation of cell migration (GO:0030335),0.43210253413248245,1.2135886723201033,0.22199170124481327,0.5394031719830854,1.0,7/17,25.03%,CCAR1;NIPBL;ACTN4;SYNE2;PAK1;HIF1A;C1QBP
69,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4435112054470671,1.221085575732537,0.23492063492063492,0.5330025475291018,1.0,8/15,31.93%,PSME4;CITED2;NFE2L2;HIF1A;EP300;CREBBP;PSMC6;RBPJ
79,positive regulation of cytokine production (GO:0001819),0.38429619215217603,1.1696760790859566,0.23713420787083753,0.6090558583209692,1.0,12/30,25.43%,DHX9;DHX36;LRRFIP1;CTNNB1;FOXP1;HMGB1;NFKB1;ATF4;HIF1A;EP300;CREBBP;RUNX1
75,cellular response to oxygen-containing compound (GO:1901701),0.38875491882813984,1.1865086192784418,0.238716148445336,0.5894849070433797,1.0,16/30,41.94%,ACTB;ANKRD1;HMGB2;DHX36;TAF1;HMGB1;JUN;SETX;NFKB1;CREB1;SNW1;CTR9;NRIP1;SOX9;IRAK1;LCOR
78,positive regulation of cellular catabolic process (GO:0031331),0.43279175687934773,1.1820832082640609,0.24338624338624337,0.5799054458346788,1.0,8/15,34.73%,CNOT1;MTDH;ZBTB20;GSK3B;HMGB1;HIF1A;APP;ATF6
84,positive regulation of cell population proliferation (GO:0008284),0.34893921911120374,1.1528790789868584,0.247,0.6220493928230318,1.0,26/56,38.34%,HNRNPU;NPM1;HMGA2;DHX9;NAP1L1;CCAR1;CDK6;SOX4;CNOT6;EZH2;KDM1A;FOXP1;SOX11;CDK4;PAK1;WWTR1;SRPK2;HES1;MEIS2;ID2;RBPJ;LAMC1;DOT1L;HDAC2;NACC1;SOX9
74,cellular response to hypoxia (GO:0071456),0.41681151004320677,1.1867596003273557,0.26632124352331604,0.5969402774893546,1.0,7/18,26.33%,LMNA;PSME4;HIF1A;EP300;HP1BP3;CREBBP;PSMC6
83,regulation of protein phosphorylation (GO:0001932),0.41199888565174997,1.1562773157163047,0.2681912681912682,0.6194680974643096,1.0,8/19,26.63%,CCND1;NPM1;FMR1;NSD1;BRD4;ATF4;PAK1;WWTR1
97,regulation of nucleic acid-templated transcription (GO:1903506),0.31543096975477963,1.0952074900090212,0.285,0.6973361149412326,1.0,43/119,30.73%,HMGA2;ATRX;FUS;MYBBP1A;CCAR1;YBX1;CHD3;SFPQ;NSD2;SBNO1;HNRNPD;SOX4;ACTN4;NSD1;ZBTB38;EZH2;CLOCK;POLR2A;BRCA2;JMJD1C;SP1;NONO;ZFHX3;SOX11;CHD7;REST;NR3C1;RNF20;NR2C2;ATF4;NSD3;HIF1A;EP300;HP1BP3;CREBBP;WWTR1;SIX1;MTF2;SP3;BAZ2A;PRDM2;ZMIZ1;COPS2
88,G1/S transition of mitotic cell cycle (GO:0000082),0.3816958649017228,1.1379122858823285,0.2887537993920973,0.636929456230449,1.0,8/24,25.93%,CCND1;CDK6;POLA1;NASP;BRD4;CDK4;PCNA;NPAT
86,cellular response to organic cyclic compound (GO:0071407),0.4078989049075137,1.141531265640417,0.29149377593361,0.6402135771344869,1.0,5/18,20.52%,ACTB;MED1;CTNNB1;TAF1;NR3C1
87,regulation of mitotic cell cycle (GO:0007346),0.412350183629866,1.1391792752805094,0.3052959501557632,0.6403985832252641,1.0,9/17,41.54%,MKI67;HNRNPU;PSME4;RNF20;PSMC6;MEIS2;APP;PRMT5;CDK1
91,ubiquitin-dependent protein catabolic process (GO:0006511),0.3690776036534586,1.1242777372562642,0.31414141414141417,0.6557518015965612,1.0,15/27,40.54%,CLOCK;PSME4;CTNNB1;TAF1;NFE2L2;TBL1X;RNF20;PSMC6;RLIM;RNF168;UBE2L3;UHRF1;RNF4;SQSTM1;TBL1XR1
105,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3036494750879713,1.0700686519042522,0.328,0.7128577603955761,1.0,41/166,20.62%,NCL;SET;ANKRD1;HMGA2;CBX5;ENO1;PA2G4;BCLAF1;MYBBP1A;CNOT1;YBX1;SMARCA4;SFPQ;NIPBL;HMGB2;NCOR1;MPHOSPH8;DHX36;BASP1;GSK3B;FMR1;CTCF;BRD7;CHD8;ZBTB38;EZH2;CLOCK;KDM1A;CBX3;SPEN;KAT6A;CITED2;KMT5A;ID3;CTNNB1;FOXP1;JUN;NONO;REST;NR3C1;ZMYND11
92,regulation of protein binding (GO:0043393),0.4022140237071631,1.1238190232053027,0.3295099061522419,0.6500724411105364,1.0,4/16,17.32%,ACTB;GSK3B;KDM1A;TAF1
94,protein ubiquitination (GO:0016567),0.34736267156053807,1.1049653908304993,0.33097880928355194,0.6897275543098982,1.0,20/38,37.64%,UBE3A;UBR2;PSME4;CTNNB1;TAF1;NFE2L2;PCNA;RNF20;HIF1A;PSMC6;RLIM;WAC;RNF168;NFX1;UBE2L3;TRIM37;UHRF1;CTR9;RNF4;TRIM33
99,regulation of intracellular signal transduction (GO:1902531),0.3377557951127353,1.0896213710548686,0.331,0.6989581500143238,1.0,26/49,41.54%,CHD4;SSRP1;CHD3;BRD7;RBBP7;KAT6A;PHF20;KMT5A;TAF15;TAF1;RBBP4;PAK1;EP300;RBBP8;TAF3;TAF2;EHMT1;HIPK2;HDAC2;BRIP1;PRMT5;WRN;RPA1;SQSTM1;BRCA1;CDK1
98,cellular macromolecule biosynthetic process (GO:0034645),0.3497632251374778,1.0921016243521469,0.3383383383383383,0.6990381987097806,1.0,22/35,49.25%,PTMA;SET;NAP1L1;TOP1;POLA1;POLR2A;PCLAF;RBBP8;MEF2A;NR4A2;BAZ2A;RPL13A;BRIP1;POLR2B;WRN;RPA1;BRCA1;CDK1;POLE;EPC1;COPS5;KAT7
93,cellular response to lipid (GO:0071396),0.3753418889193313,1.1089744603637026,0.34282807731434384,0.6851576239883203,1.0,15/25,41.94%,ANKRD1;HMGB2;MED1;HMGB1;NR3C1;SETX;NFKB1;UBE2L3;CREB1;SNW1;CTR9;NRIP1;SOX9;IRAK1;LCOR
112,regulation of Notch signaling pathway (GO:0008593),-0.22583926754832145,-1.0522424883629844,0.34615384615384615,1.0,0.7783558792924038,16/16,77.88%,NOTCH1;KAT2B;GATA2;STAT3;BEND6;SREBF2;AKT1;EGFR;YAP1;JAG2;SNW1;RBPJ;ZMIZ1;CREBBP;EP300;ZBTB7A
100,regulation of cell cycle (GO:0051726),0.3396885146983689,1.0891147729239872,0.34804413239719156,0.6934402919663132,1.0,13/46,23.82%,HNRNPU;CCND1;HMGA2;MYBBP1A;CDK6;ANKRD17;CITED2;JUN;PCLAF;RBBP4;CDK4;RNF20;EP300
96,internal peptidyl-lysine acetylation (GO:0018393),0.3929803303127012,1.0969869261490366,0.35368421052631577,0.6990997150047925,1.0,7/17,25.23%,KAT6A;BRD8;PHF20;MORF4L2;NAA50;EP300;CREBBP
102,regulation of signal transduction by p53 class mediator (GO:1901796),0.33475947814396256,1.076593768228855,0.358,0.7152228909565682,1.0,24/46,41.54%,CHD4;SSRP1;CHD3;BRD7;RBBP7;KAT6A;PHF20;KMT5A;TAF15;TAF1;RBBP4;EP300;RBBP8;TAF3;TAF2;EHMT1;HIPK2;HDAC2;BRIP1;PRMT5;WRN;RPA1;BRCA1;CDK1
101,regulation of osteoblast differentiation (GO:0045667),0.38164547963174766,1.0873181764314952,0.3743482794577685,0.6917631888566244,1.0,7/18,26.63%,DDX5;CDK6;SOX11;REST;RUNX2;ATF4;WWTR1
95,peptidyl-serine modification (GO:0018209),0.3919765915671073,1.0974744556972518,0.37591623036649213,0.7049513465915637,1.0,14/17,52.95%,TOP1;GSK3B;TAF1;HPF1;SRPK2;TLK1;TLK2;HIPK2;PARP1;PARP2;CDK1;HIPK1;PKN1;HIPK3
108,"transcription, DNA-templated (GO:0006351)",0.3169560585573053,1.059788974695871,0.38038038038038036,0.7220228850468072,1.0,31/77,36.64%,PTMA;SMARCA5;DDX5;DEK;DDX21;NFIX;SSRP1;NFIC;POLR2A;TAF15;TAF1;UBTF;SETX;NFKB1;ATF4;CCNT1;TSC22D1;TAF3;MEF2A;NR4A2;KLF13;BAZ2A;RSF1;COPS2;TAF2;NFX1;CCNT2;NCOA6;CTR9;PARP1;GTF2F1
103,positive regulation of multicellular organismal process (GO:0051240),0.342899187943851,1.0725779702850653,0.38716148445336007,0.7196229511615018,1.0,15/36,32.73%,ENO1;GNAS;RIF1;MED1;EZH2;KDM1A;CTNNB1;SOX11;REST;NR2C2;C1QBP;WWTR1;SIX1;OGT;EHMT1
104,regulation of angiogenesis (GO:0045765),0.3754745893154341,1.0723187384828388,0.38923395445134573,0.7134206206728774,1.0,13/19,47.45%,HMGA2;MTDH;CTNNB1;SP1;HIF1A;RUNX1;ETS1;HIPK2;GTF2I;ATF2;BRCA1;HIPK1;ECM1
111,positive regulation of cell differentiation (GO:0045597),0.33261173401536415,1.0545604235155945,0.39899497487437185,0.7172636137785735,1.0,18/37,38.34%,PA2G4;DHX36;EZH2;ASXL2;CTNNB1;SOX11;REST;RUNX2;NFKB1;WWTR1;NUDT21;MEF2A;TCF4;ID2;SIN3A;CREB1;GPC1;SOX9
110,DNA metabolic process (GO:0006259),0.31860452551579876,1.0550328767113997,0.403,0.7225457024484145,1.0,35/63,46.15%,TOP2A;NPM1;DDX21;SMC1A;TOP1;RIF1;HMGB2;POLA1;RAD21;TOP2B;HELLS;PSME4;DNMT1;SMARCAD1;HMGB1;PURA;PCNA;RBBP8;INO80;SRPK2;PARG;UHRF1;DOT1L;PARP1;DDX23;WRN;RPA1;PARP2;BRCA1;KMT5B;CDK1;ZBTB1;POLE;TRRAP;TCF7L2
109,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.36151305568518943,1.0596588588227878,0.4065372829417773,0.7157819881655791,1.0,7/21,19.92%,CLOCK;UBR2;PSME4;CTNNB1;TAF1;NFE2L2;TBL1X
113,regulation of myeloid cell differentiation (GO:0045637),0.34656291534522354,1.0517283666491342,0.42201834862385323,0.7183885615284297,1.0,11/25,35.94%,PURB;CDK6;KMT2A;KMT2E;EP300;CREBBP;RUNX1;MEIS2;KMT2C;SIN3A;CTR9
106,cellular protein-containing complex assembly (GO:0034622),0.3895620444240635,1.061484372612367,0.42231491136600624,0.7306363948396409,1.0,3/15,10.01%,TPR;DHX9;NUP153
115,positive regulation of histone methylation (GO:0031062),0.3741283903048177,1.0440154277061455,0.42311770943796395,0.7257868055636115,1.0,9/16,40.74%,RIF1;KMT2A;DNMT1;CTNNB1;MTF2;OGT;SNW1;CTR9;BRCA1
107,regulation of signal transduction (GO:0009966),0.37530689088217,1.061000046766781,0.4254658385093168,0.7253507433411017,1.0,10/17,41.24%,NUCKS1;UBTF;CREBBP;RUNX1;WWTR1;OGT;APP;SNW1;RGS12;IRAK1
114,double-strand break repair via nonhomologous end joining (GO:0006303),0.37666552521119406,1.0485071482435542,0.42782426778242677,0.7200480030127079,1.0,8/17,33.13%,RIF1;NSD2;HMGB2;POLA1;HMGB1;ZBTB7A;RNF168;KDM2A
116,positive regulation of binding (GO:0051099),0.3660375983642321,1.0428510139020861,0.42988741044012285,0.7225453094018778,1.0,12/19,46.15%,DHX9;HMGB2;GSK3B;TAF1;HMGB1;HES1;APP;HIPK2;SKI;CEBPG;ADD1;TCF7L2
118,regulation of cell population proliferation (GO:0042127),0.30169592110849347,1.0317089523371532,0.435,0.7392784090632787,1.0,43/90,42.74%,LMNA;NPM1;NAP1L1;PBRM1;CCAR1;CDK6;HMGB2;SOX4;CTCF;BRD7;CNOT6;EZH2;CTNNB1;JUN;RBBP4;SOX11;REST;CDK4;ARID2;PAK1;RBFOX2;HP1BP3;RUNX1;WWTR1;SIX1;SRPK2;HES1;MEIS2;ETS1;ID2;APP;UHRF1;DOT1L;E2F7;HDAC2;NACC1;SOX9;ASH2L;JUNB;SKI;CTBP2;PTPN14;FOSL1
117,MAPK cascade (GO:0000165),0.3700855902619991,1.0346971612525342,0.4434060228452752,0.7380391361131383,1.0,10/17,41.54%,PSME4;SPTAN1;SETX;NFKB1;PAK1;PSMC6;MEF2A;PIK3CA;SOX9;CDK1
119,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.36007890114683344,1.0277658025715668,0.44881075491209926,0.7436400171011026,1.0,9/19,36.14%,CCND1;CNOT1;SOX4;CNOT6;PCNA;EP300;E2F8;WAC;E2F7
122,regulation of gene expression (GO:0010468),0.2855649826249471,1.0166424478458325,0.45,0.7535145179759511,1.0,64/189,29.73%,HMGA2;ATRX;FUS;MYBBP1A;CCAR1;CDK6;YBX1;CHD3;SFPQ;NSD2;SBNO1;DHX36;HNRNPD;SOX4;GSK3B;CTCF;NSD1;ZBTB38;MED1;EZH2;CLOCK;POLR2A;CITED2;DNMT1;BRCA2;TAF1;DICER1;FOXP1;JMJD1C;YTHDC1;YY1;NFE2L2;SP1;NONO;ZFHX3;SOX11;CHD7;REST;NR3C1;CDK4;RRP1B;RNF20;NFKB1;NR2C2;ATF4;NSD3;HIF1A;EP300;HP1BP3;CREBBP;RUNX1;PEG3;NPAT;WWTR1;NUDT21;SIX1;SRPK2;MTF2;SP3;HMG20B;BAZ2A;PRDM2;ETS1;ID2
120,positive regulation of Wnt signaling pathway (GO:0030177),0.36269317187891514,1.0171438453577601,0.4677754677754678,0.7650839433732907,1.0,9/17,41.44%,SMARCA4;SOX4;PSME4;TBL1X;NFKB1;PSMC6;ZEB2;TBL1XR1;SKI
126,DNA replication (GO:0006260),0.33138106288345476,1.0125242727031352,0.47373737373737373,0.7396166096847112,1.0,5/28,10.21%,SET;NAP1L1;TOP1;POLA1;BAZ1A
123,regulation of macromolecule metabolic process (GO:0060255),0.32582054215066103,1.0154347332641724,0.47527749747729564,0.7501257714873875,1.0,16/31,40.44%,CDK6;YBX1;HNRNPD;CTCF;FOXP1;REST;CDK4;HIF1A;PEG3;NPAT;HMG20B;PRDM2;APP;PCBP1;CGGBP1;TOB2
128,mitotic cell cycle phase transition (GO:0044772),0.34794292155945766,1.008234735969645,0.47530864197530864,0.7388919291732099,1.0,3/20,7.91%,CCND1;CDK6;NASP
121,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35213047327141633,1.016668749973636,0.4792099792099792,0.7597275117765555,1.0,11/19,41.44%,CITED2;SKIL;SOX11;ZBTB7A;EP300;CREBBP;ZEB2;SNW1;HIPK2;TRIM33;SKI
124,cytokine-mediated signaling pathway (GO:0019221),0.33207151022418335,1.01451185553189,0.4792719919110212,0.7466142650211224,1.0,15/30,41.24%,CCND1;ANXA2;SMARCA4;ACTN4;PSME4;NFKB1;HIF1A;POU2F1;PSMC6;LMNB1;CTR9;PIK3CA;SQSTM1;JUNB;IRAK1
125,regulation of primary metabolic process (GO:0080090),0.3378630691233455,1.0134292561439278,0.48328267477203646,0.7435042306973041,1.0,12/27,34.83%,NCOR1;MED1;PSME4;CHD9;SP1;TBL1X;CREBBP;PSMC6;ID2;NCOR2;SIN3A;NCOA6
127,heart development (GO:0007507),0.3591851942751523,1.0082818357205794,0.4863731656184486,0.7445588477107101,1.0,9/17,38.34%,NIPBL;SOX4;CITED2;TCF25;CHD7;MEF2A;ID2;NCOA6;SOX9
130,regulation of phosphorylation (GO:0042325),0.37084557112009353,0.995894589484294,0.5026232948583421,0.7567442885627733,1.0,7/15,32.33%,TPR;NUP153;ZBTB7A;HIF1A;EP300;OGT;APP
131,regulation of canonical Wnt signaling pathway (GO:0060828),0.3281063254418855,0.992122834319974,0.5101419878296146,0.7598728482920989,1.0,15/29,42.34%,SOX4;GSK3B;CHD8;PSME4;CTNNB1;TBL1X;JADE1;NFKB1;PSMC6;WWTR1;ZEB2;GLI3;SOX9;TBL1XR1;LIMD1
133,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3238296144198332,0.9851863023485643,0.5121457489878543,0.7645187490592968,1.0,8/28,22.52%,CCND1;DHX36;MED1;MED13;CTNNB1;CDK4;RUNX2;NFKB1
137,proteasomal protein catabolic process (GO:0010498),0.35039280346498614,0.9771833461854382,0.5124740124740125,0.7602393392887242,1.0,6/16,26.33%,CLOCK;PSME4;CTNNB1;NFE2L2;TBL1X;PSMC6
129,protein modification by small protein removal (GO:0070646),0.314067098529472,0.9995671138880221,0.5175175175175175,0.7546777849823928,1.0,22/40,47.65%,ACTB;ASXL2;USP16;PSME4;YY1;INO80D;HIF1A;EP300;INO80;MYSM1;PSMC6;OGT;COPS2;SMAD1;HCFC1;BRCA1;ACTL6A;CDK1;UCHL5;TRRAP;ASXL1;COPS5
132,negative regulation of macromolecule metabolic process (GO:0010605),0.31773618136468407,0.9861392989262169,0.5231854838709677,0.7681154549094549,1.0,13/31,32.33%,CITED2;DNMT1;TAF1;DICER1;FOXP1;YY1;SOX11;REST;NFKB1;HIF1A;RUNX1;ID2;APP
135,negative regulation of G0 to G1 transition (GO:0070317),0.33336334526676525,0.9818571806833775,0.5310274669379451,0.7551385042156016,1.0,8/24,24.22%,CBX5;EZH2;RBBP7;CBX3;SUZ12;MGA;RBBP4;RBBP8
136,regulation of G0 to G1 transition (GO:0070316),0.33336334526676525,0.9818571806833775,0.5310274669379451,0.7551385042156016,1.0,8/24,24.22%,CBX5;EZH2;RBBP7;CBX3;SUZ12;MGA;RBBP4;RBBP8
140,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.33050844863695905,0.9594646625917286,0.537590113285273,0.7829279743240278,1.0,9/20,36.14%,ATRX;CNOT1;SOX4;CNOT6;PCNA;EP300;E2F8;HIPK2;E2F7
134,protein modification by small protein conjugation (GO:0032446),0.31365036382571226,0.9851229622125351,0.5384615384615384,0.7589200227863587,1.0,19/35,43.04%,TPR;NUP153;UBR2;NFE2L2;PCNA;RNF20;HIF1A;RLIM;WAC;RNF168;NFX1;UBE2L3;UHRF1;CTR9;TRIM33;BRCA1;PIAS2;NUP98;CAND1
141,nucleotide-excision repair (GO:0006289),0.32946645053141294,0.95756807843116,0.5524691358024691,0.7813700859013046,1.0,15/22,50.25%,POLA1;HMGN1;POLR2A;BRCA2;PCNA;EP300;COPS2;PARP1;BRIP1;POLR2B;RPA1;POLE;ERCC6;COPS5;GTF2H1
147,positive regulation of phosphorylation (GO:0042327),0.3405747035998454,0.9448557923762504,0.5604166666666667,0.7758423659405028,1.0,5/17,23.32%,CCND1;ZBTB20;FMR1;PAK1;HIF1A
142,regulation of DNA repair (GO:0006282),0.32983663713846934,0.9564497681659441,0.5620512820512821,0.7781628438825292,1.0,3/21,4.80%,DEK;DHX9;SMCHD1
143,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.33530234701676587,0.9521225172295711,0.56656346749226,0.7821997260794368,1.0,12/18,49.85%,KDM1A;ID3;TAF1;TAF3;HES1;ID2;TRIM37;HDAC2;IRAK1;CEBPG;TCF7L2;CTNNBIP1
145,regulation of cell growth (GO:0001558),0.34470976069101866,0.948546433033324,0.5690376569037657,0.7790079729174818,1.0,5/16,24.62%,ENO1;SMARCA4;RBBP7;JADE1;INO80
139,negative regulation of cell population proliferation (GO:0008285),0.29408479915669977,0.9600414252320872,0.5865865865865866,0.7874340172282291,1.0,13/51,22.92%,LMNA;NPM1;PBRM1;CDK6;SOX4;CTCF;BRD7;CTNNB1;RBBP4;SOX11;REST;ARID2;PAK1
138,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27476413038651826,0.9657274911363743,0.592,0.780668141878166,1.0,90/154,53.35%,SET;HMGA2;CBX5;ENO1;PA2G4;BCLAF1;MYBBP1A;SMARCA4;SFPQ;NIPBL;HMGB2;NCOR1;MPHOSPH8;BASP1;CTCF;BRD7;CHD8;ZBTB38;EZH2;CLOCK;KDM1A;CBX3;SPEN;KAT6A;CITED2;KMT5A;ID3;CTNNB1;FOXP1;JUN;NONO;REST;NR3C1;ZMYND11;ZBTB7A;RUNX2;RBFOX2;BTAF1;POU2F1;HES1;SP3;ID2;RSF1;ARID4A;RCOR1;NCOR2;COPS2;RLIM;RBPJ;EHMT1;SIN3A;SMARCC2;SNW1;GLI3;PHF12;HDAC2;TRIM33;NACC1;SOX9;KDM5C;MBTD1;PBXIP1;BRCA1;ELK3;CTBP2;LIMD1;ARID5B;ZKSCAN3;PHC2;PHC3;ATXN1;GATAD2A;TCF7L2;EPC1;SMARCE1;ZEB1;BCOR;SBNO2;NKAP;RCOR3;KAT7;TFDP2;MECP2;YEATS2;ATF7IP;CTBP1;UIMC1;SFMBT1;HMGA1;BCL7A
152,regulation of lipid metabolic process (GO:0019216),0.31281902002407774,0.9225684306430058,0.602238046795524,0.7937151828722077,1.0,10/24,34.83%,NCOR1;MED1;CHD9;SP1;TBL1X;CREBBP;ID2;NCOR2;SIN3A;NCOA6
150,circulatory system development (GO:0072359),0.33889726205756904,0.9300004193184879,0.6027397260273972,0.7900736324769315,1.0,8/15,38.34%,SOX4;CITED2;TCF25;MEF2A;ID2;NCOA6;PIK3CA;SOX9
155,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.32818832824651556,0.9141290263757758,0.604989604989605,0.7941830941764307,1.0,12/16,56.36%,CNOT1;SOX4;CNOT6;PCNA;EP300;E2F8;E2F7;CDK1;TFDP1;TFDP2;CNOT7;PML
146,"DNA-templated transcription, initiation (GO:0006352)",0.2887729546398158,0.9451387665150404,0.6082164328657315,0.780589500319833,1.0,25/60,36.64%,SMARCA5;NCOR1;MED1;POLR2A;TAF15;TAF1;TBL1X;UBTF;NR3C1;NR2C2;CAVIN1;TAF3;CREBBP;WWTR1;TEAD1;NR4A2;RSF1;NCOR2;RBPJ;TAF2;POLR1A;E2F3;NCOA6;SNW1;GTF2F1
158,post-translational protein modification (GO:0043687),0.33177773901112595,0.9033006193615686,0.6085594989561587,0.7987437644238993,1.0,7/15,33.93%,RBBP7;PSME4;HIF1A;PSMC6;COPS2;APP;LAMC1
144,DNA repair (GO:0006281),0.284204860143974,0.9511444985094384,0.617,0.7789619999101728,1.0,18/67,25.33%,SMARCA5;NPM1;NUCKS1;HMGA2;SMC1A;BAZ1B;NSD2;POLA1;RAD21;SETD2;PSME4;DDX1;BRCA2;SETX;PCNA;RBBP8;INO80;HPF1
157,cellular response to oxidative stress (GO:0034599),0.3273424431354137,0.9036698183809356,0.6192468619246861,0.8031882294508453,1.0,5/15,23.32%,JUN;NFE2L2;SETX;ATF4;HIF1A
156,regulation of megakaryocyte differentiation (GO:0045652),0.3189912133093022,0.9072373131858203,0.6200828157349897,0.8017364270536446,1.0,7/18,33.33%,KMT2A;HMGB2;KMT2E;EP300;RUNX1;KMT2C;SIN3A
149,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2946873021764923,0.9316416552035768,0.6208625877632898,0.7921667047408368,1.0,11/39,23.82%,NPM1;DHX9;MTDH;SMARCA4;CLOCK;KDM1A;CTNNB1;TAF1;ZBTB7A;NFKB1;EP300
151,positive regulation of DNA metabolic process (GO:0051054),0.30833443325752413,0.9240690453553432,0.6225641025641026,0.7959836179013896,1.0,4/25,8.31%,ATRX;DHX9;SMCHD1;DHX36
148,protein deubiquitination (GO:0016579),0.2946101675119359,0.9372579792159499,0.623,0.7860488757784305,1.0,22/42,47.65%,ACTB;ASXL2;USP16;PSME4;YY1;INO80D;HIF1A;EP300;INO80;MYSM1;PSMC6;ENY2;OGT;SMAD1;HCFC1;BRCA1;ACTL6A;CDK1;UCHL5;TRRAP;ASXL1;COPS5
154,negative regulation of cell cycle process (GO:0010948),0.3082473909542596,0.9199706113913003,0.6265182186234818,0.7883768536640334,1.0,16/26,50.45%,CBX5;EZH2;RBBP7;CBX3;SUZ12;MGA;RBBP4;RBBP8;E2F8;EHMT1;E2F7;BRCA1;PHC3;EPC1;TFDP1;TFDP2
153,histone H4 acetylation (GO:0043967),0.2987925170169379,0.9215184550303568,0.6378269617706237,0.7905345251837941,1.0,18/33,46.45%,KMT2A;EP400;BRD8;PHF20;BRCA2;MORF4L2;JADE1;EP300;OGT;MSL1;KANSL2;HCFC1;MORF4L1;KANSL3;ATF2;ACTL6A;TRRAP;EPC1
161,regulation of programmed cell death (GO:0043067),0.31266835641206936,0.8939632542269572,0.6422680412371135,0.799938874678996,1.0,4/20,9.91%,ACTN1;ANP32B;ACTN4;ANP32E
159,histone deacetylation (GO:0016575),0.3002519679562672,0.8986371694171974,0.6527068437180796,0.8019269034398684,1.0,12/25,40.54%,SFPQ;MIER1;SMARCAD1;MORF4L2;TBL1X;REST;BAZ2A;RCOR1;SIN3A;MORF4L1;HDAC2;TBL1XR1
162,protein-containing complex assembly (GO:0065003),0.28096857596007657,0.8755966851342596,0.6609137055837564,0.8257907736701691,1.0,16/32,46.35%,DHX9;SMARCA4;KMT2A;GSK3B;CTNNB1;EP300;CREBBP;TEAD1;HES1;LAMC1;SOX9;ASH2L;CAND1;TRRAP;TCF7L2;BCL9L
163,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3074636184849296,0.8667774423108916,0.6645702306079665,0.8352227017072311,1.0,10/18,46.15%,GSK3B;CHD8;PSME4;JADE1;PSMC6;WWTR1;GLI3;SOX9;LIMD1;TCF7L2
164,peptidyl-lysine trimethylation (GO:0018023),0.311094788836889,0.8612592657213125,0.6694825765575502,0.8387310713235507,1.0,7/15,41.04%,KMT2A;SETD5;SETD2;TET3;OGT;CTR9;KMT5B
160,histone modification (GO:0016570),0.2739649922201999,0.8962829832698483,0.7,0.8009547810118864,1.0,24/55,40.54%,BAZ1B;NSD1;EZH2;MIER1;USP16;KAT6A;BRD8;PHF20;MORF4L2;NAA50;TBL1X;NSD3;EP300;CREBBP;ENY2;BAZ2A;RCOR1;EHMT1;SIN3A;MORF4L1;UHRF1;HDAC2;PARP2;TBL1XR1
168,hemopoiesis (GO:0030097),0.29615089995443,0.8164960242654421,0.7133757961783439,0.8848442506348259,1.0,5/15,25.43%,KMT2A;KAT6A;RUNX2;ATF4;RUNX1
166,negative regulation of cell differentiation (GO:0045596),0.2739810707567537,0.8497437699236461,0.7152917505030181,0.847042537880147,1.0,10/33,29.73%,HNRNPU;CDK6;ANP32B;MED1;SUZ12;REST;WWTR1;HES1;MEIS2;ID2
165,protein phosphorylation (GO:0006468),0.26880739943977616,0.8525549107293364,0.7331995987963892,0.8475325023431842,1.0,16/41,35.44%,TOP1;BAZ1B;BRD2;CDK6;GSK3B;TAF1;CDK4;PAK1;CCNT1;SRPK2;COPS2;TLK1;TLK2;APP;CREB1;HIPK2
167,phosphorylation (GO:0016310),0.26732477933883286,0.8459210629035188,0.7357357357357357,0.8474510474043222,1.0,19/40,42.34%,TOP1;BRD2;CDK6;GSK3B;TAF1;CDK4;PAK1;CCNT1;SRPK2;COPS2;TLK1;TLK2;APP;CREB1;HIPK2;PIK3CA;IRAK1;CDK1;LIMD1
169,DNA-dependent DNA replication (GO:0006261),0.27072396520669945,0.8041886688385971,0.7402862985685071,0.8959672909662915,1.0,16/24,56.56%,DDX21;POLA1;BAZ1A;PSME4;PURA;PSMC6;SRPK2;DDX23;WRN;RPA1;MCMBP;POLE;NOC3L;HMGA1;WDHD1;SSBP1
174,histone methylation (GO:0016571),0.2820597149788369,0.7737120763077973,0.7552521008403361,0.9070493055515844,1.0,6/15,38.84%,NSD1;EZH2;NSD3;CREBBP;EHMT1;PRMT5
172,snRNA transcription (GO:0009301),0.2836030195926777,0.7750932012000326,0.7863874345549738,0.9106057602456957,1.0,7/15,39.14%,POLR2A;SP1;CCNT1;POU2F1;CCNT2;GTF2F1;POLR2B
173,snRNA transcription by RNA polymerase II (GO:0042795),0.2836030195926777,0.7750932012000326,0.7863874345549738,0.9106057602456957,1.0,7/15,39.14%,POLR2A;SP1;CCNT1;POU2F1;CCNT2;GTF2F1;POLR2B
176,negative regulation of Wnt signaling pathway (GO:0030178),0.26542540418580374,0.760954357396923,0.7917098445595855,0.9111104634686963,1.0,11/20,49.85%,GSK3B;CHD8;PSME4;JADE1;PSMC6;WWTR1;GLI3;SOX9;LIMD1;TCF7L2;CTNNBIP1
171,positive regulation of signal transduction (GO:0009967),0.2578819111255951,0.7892697306430956,0.7977755308392316,0.9043202463284856,1.0,15/29,47.05%,SMARCA4;ASXL2;CITED2;HIF1A;EP300;CREBBP;ZMIZ1;ITGA5;RBPJ;SNW1;MYO1C;SKI;CTBP2;UCHL5;ASXL1
177,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2742197179347777,0.7580989005477544,0.8014705882352942,0.9091881247958412,1.0,5/15,32.53%,DDX5;JUN;RUNX2;ZMIZ1;SMAD1
178,positive regulation of protein phosphorylation (GO:0001934),0.2719163124182443,0.7472509091228502,0.8059071729957806,0.9161023421577535,1.0,6/16,38.34%,CCND1;FMR1;PAK1;ITGA5;APP;SOX9
179,"DNA-templated transcription, elongation (GO:0006354)",0.25778919609693857,0.7460355512652618,0.814968814968815,0.9071054049579899,1.0,13/19,58.86%,SSRP1;POLR2A;SETD2;CCNT1;CCNT2;CTR9;GTF2F1;POLR2B;GTF2H1;GTF2F2;CDK7;EAF1;MLLT3
180,transcription elongation from RNA polymerase II promoter (GO:0006368),0.25778919609693857,0.7460355512652618,0.814968814968815,0.9071054049579899,1.0,13/19,58.86%,SSRP1;POLR2A;SETD2;CCNT1;CCNT2;CTR9;GTF2F1;POLR2B;GTF2H1;GTF2F2;CDK7;EAF1;MLLT3
181,beta-catenin-TCF complex assembly (GO:1904837),0.26323013333056616,0.7422694683158957,0.8168574401664932,0.906038036950278,1.0,8/16,46.35%,SMARCA4;CTNNB1;EP300;CREBBP;ASH2L;TRRAP;TCF7L2;BCL9L
182,negative regulation of multicellular organismal process (GO:0051241),0.25114939526092395,0.7226957136054827,0.8276923076923077,0.9201952532648667,1.0,11/19,53.15%,GSK3B;NFIB;BRCA2;KLF7;ATF4;RBPJ;SOX9;TFE3;HOXC10;SFMBT1;USF3
170,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24715406351599944,0.7960276726146234,0.8304914744232698,0.9010687441597198,1.0,21/50,40.54%,NCOR1;MED1;POLR2A;TAF15;TAF1;TBL1X;NR3C1;NR2C2;TAF3;CREBBP;WWTR1;TEAD1;NR4A2;NCOR2;RBPJ;TAF2;E2F3;SNW1;GTF2F1;POLR2B;TBL1XR1
184,regulation of autophagy (GO:0010506),0.2534794491475385,0.7096864725554085,0.8425443169968717,0.9222235172136147,1.0,6/17,34.73%,MTDH;GSK3B;HMGB1;EP300;TLK2;ATF6
175,cellular protein modification process (GO:0006464),0.23472878361827704,0.770724614682104,0.852,0.9052310807859367,1.0,26/57,43.04%,BRD2;CDK6;GSK3B;RBBP7;PSME4;TAF1;CDK4;PAK1;HIF1A;CCNT1;PSMC6;SRPK2;COPS2;TLK1;TLK2;APP;LAMC1;UBE2L3;CREB1;HIPK2;PARP1;PARP2;IRAK1;CDK1;PTPN14;CAND1
183,nervous system development (GO:0007399),0.2332339438147676,0.7207391963406626,0.8533872598584429,0.9167783690237314,1.0,10/30,30.33%,CHD7;NR2C2;IRF2BPL;EP300;RBFOX2;NAV1;WWTR1;TEAD1;HES1;ZEB2
185,apoptotic process (GO:0006915),0.2484898467558752,0.7044623680767168,0.8556593977154725,0.9216484369724453,1.0,7/18,38.24%,BCLAF1;JADE1;EP300;OGT;APP;PARP1;PIK3CA
189,positive regulation of DNA repair (GO:0045739),0.21732697189669004,0.6367275078314141,0.9032586558044806,0.9612661596080087,1.0,2/21,4.80%,DHX9;SMCHD1
187,histone H3 acetylation (GO:0043966),-0.15204081632653063,-0.6666187050211818,0.9047619047619048,1.0,0.9885535900104059,19/19,85.19%,TAF5;KAT2B;MYOD1;TAF12;LEF1;DR1;ING5;WDR5;KAT14;POLE3;KAT6B;TADA2A;BRPF1;YEATS2;KAT7;BRD1;JADE1;BRCA2;KAT6A
186,histone acetylation (GO:0016573),0.21674763935005362,0.6848376286062741,0.906813627254509,0.9323781957886043,1.0,10/39,25.23%,EP400;KAT6A;BRD8;PHF20;BRCA2;MORF4L2;NAA50;JADE1;EP300;CREBBP
193,positive regulation of epithelial cell proliferation (GO:0050679),0.21961261332280244,0.6116543689368973,0.9142259414225942,0.9658026472534312,1.0,8/16,47.45%,HMGB2;SOX11;HIF1A;LAMC1;SOX9;NME2;TCF7L2;ECM1
191,protein deacetylation (GO:0006476),0.2104232513709473,0.6191241186244808,0.925281473899693,0.9669312417676906,1.0,9/22,40.54%,MIER1;MORF4L2;TBL1X;BAZ2A;RCOR1;SIN3A;MORF4L1;HDAC2;TBL1XR1
194,negative regulation of signal transduction (GO:0009968),0.21154911097443935,0.5998559654779656,0.9302083333333333,0.9669220975944505,1.0,6/18,37.54%,CNOT1;EZH2;ZBTB7A;NR4A2;GLI3;GPC1
195,innate immune response (GO:0045087),0.21482532219102543,0.59079587598739,0.9343915343915344,0.9666218922397619,1.0,5/16,32.33%,ANKRD17;SETD2;HMGB1;SRPK2;APP
190,negative regulation of intracellular signal transduction (GO:1902532),-0.14735772357723578,-0.6328518716395852,0.9491525423728814,1.0,0.9937565036420395,15/15,85.59%,ARNTL;TLE1;PRDM15;SH2B3;AJUBA;PLEKHA1;SIRT1;AKT1;PRKAA1;NOC2L;HDAC7;URI1;LIMD1;ZMYND11;UBR2
196,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.20174395530035294,0.5626584453428553,0.9525316455696202,0.9741603468656498,1.0,8/16,48.75%,SKIL;ZBTB7A;SMAD1;HIPK2;TRIM33;SKI;BCL9L;SMAD5
188,response to ionizing radiation (GO:0010212),-0.12602860065548832,-0.6431069270177989,0.9714285714285714,1.0,0.991675338189386,14/18,47.55%,ABRAXAS1;EYA3;MYC;TICRR;EYA1;PAXIP1;MSH2;RNF8;SIRT1;MTA1;PRKAA1;RAD51;BRCC3;UIMC1
197,histone lysine demethylation (GO:0070076),0.1849174064450203,0.5085745458205754,0.9723991507430998,0.9878767579403116,1.0,3/15,20.12%,KDM1A;JMJD1C;KDM5A
192,regulation of fat cell differentiation (GO:0045598),-0.12817904374364192,-0.61758642080456,0.9782608695652174,0.9604807496435119,0.9937565036420395,16/16,87.49%,ARNTL;FOXO1;GPS2;CARM1;GATA2;WDFY2;PPARD;PPARG;SIRT1;AKT1;YAP1;ASXL1;CREB1;ID2;WWTR1;ASXL2
198,histone H3-K4 methylation (GO:0051568),0.16495507838957135,0.4649952451976427,0.9873684210526316,0.9926559315497328,1.0,6/17,40.94%,KMT2A;TET3;OGT;KMT2C;CTR9;ASH2L
199,histone lysine methylation (GO:0034968),0.1395700775431177,0.4133541874977972,0.9928934010152284,0.9946076446376306,1.0,2/22,12.01%,KMT2A;EZH2
